Aflibercept - HY-108801
Nur noch %1 verfügbar
Catalog #
HY-108801
Ab
548,00 €
Aflibercept (VEGF Trap) is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR1 and VEGFR2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease[1][2][3].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-108801/Aflibercept-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Isolate blue ice and the product with bubble pack to avoid direct contact |
| Application | Metabolism-protein/nucleotide metabolism |
| Alternative Names | VEGF Trap; VEGF-TRAPR1R2; VEGF-trapR1 |
| CAS | 862111-32-8 |
| Storage | Store at 4°C for 2 years, do not freeze |
| MWT | N/A |
| Solubility | 10 mM in DMSO |
| Clinical Information | Launched |
| Target | VEGFR |
| Application: | Metabolism-protein/nucleotide metabolism |
|---|